跳至主要内容
临床试验/ITMCTR2000003627
ITMCTR2000003627尚未招募1 期

Randomized controlled clinical evaluation of Sijunzi Decoction in the treatment of nonalcoholic fatty liver disease with spleen deficiency syndrome based on the theory of

onghua Hospital, Shanghai University of traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • (1) Those who sign the informed consent form;
  • (2) The age ranged from 18 to 65 years old;
  • (3) It met the diagnostic criteria of NAFLD in western medicine;
  • (4) TCM Syndrome Differentiation for spleen deficiency syndrome patients.

排除标准

  • (1) Drug-induced liver injury, autoimmune hepatitis A, B, C, e, etc;
  • (2) Patients wit
  • h severe primary diseases of heart, brain, kidney, lung, endocrine, blood, metabolism and gastrointestinal tract, or mental patients;
  • (3) Creatinine (CR) was higher than the upper limit of normal value;
  • (4) People who use drugs to lose weight;
  • (5) Alcoholics or drug addicts;
  • (6) Pregnant women, lactating women or those who are preparing for pregnancy in the near future and those who use estrogen contraception;
  • (7) People with allergic constitution and allergic to many kinds of drugs, as well as the components of this medicine or its prescription;
  • (8) Those who are in critical condition and are difficult to evaluate the efficacy and safety of new drugs;
  • (9) Patients are not willing to cooperate.

研究者

发起方
onghua Hospital, Shanghai University of traditional Chinese Medicine

相似试验